Scientists test 'Rechallenge' strategy to fight back when colorectal cancer returns
Disease control
Not yet recruiting
This study is testing whether restarting a specific two-drug combination can help control advanced colorectal cancer in patients who have a particular genetic mutation (BRAF V600E). The 25 participants have already been treated with similar drugs that initially worked for at leas…
Phase: PHASE2 • Sponsor: Vall d'Hebron Institute of Oncology • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC